Article Information
History
- May 28, 2023.
Article Versions
- Version 1 (November 14, 2022 - 11:24).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Ruixin Song1,#,
- Chao Yang2,#,
- Jiayin Wang1,#,
- Qianqian Li2,#,
- Jing Chen1,#,
- Kai Sun3,
- Hongmin Lv2,
- Yankai Yang2,
- Jing Liang2,
- Qing Ye2,
- YanYing Gao2,
- Jun Li2,
- Ying Li2,
- Junqing Yan2,
- Ying Liu2,
- Tao Wang2,
- Changen Liu2,
- Fei Wang2,
- Weili Yin2 and
- Huiling Xiang2,*
- 1The Third Central Clinical College of Tianjin Medical University, Department of Gastroenterology and Hepatology, Tianjin Third Central Hospital, Tianjin Key Laboratory of Extracorporeal Life Support for Critical Diseases, Artificial Cell Engineering Technology Research Center, Tianjin Institute of Hepatobiliary Disease
- 2Department of Gastroenterology and Hepatology, Tianjin Third Central Hospital, Tianjin
- 3Tianjin Hongqiao Hospital, Tianjin, China
- ↵*huilingxiang{at}163.com
Posted May 28, 2023.
Immune response of primary and booster immunity of SARS-CoV-2 vaccination among patients with chronic liver disease
